ProShare Advisors
CDNA icon

ProShare Advisors’s CareDx CDNA Stock Holding History

ProShare Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,179
Closed -$218K – 2026
2025
Q2 		$218K Buy
11,179
+47
+0.4% +$835 ﹤0.01% 1667
2025
Q1 		$198K Sell
11,132
-3,108
-22% -$66.9K ﹤0.01% 1693
2024
Q4 		$305K Buy
14,240
+4,685
+49% +$114K ﹤0.01% 1619
2024
Q3 		$298K Buy
+9,555
New +$238K ﹤0.01% 1467
2022
Q2 		– Sell
-9,490
Closed -$351K – 1839
2022
Q1 		$351K Sell
9,490
-1,563
-14% -$60.9K ﹤0.01% 1519
2021
Q4 		$503K Buy
11,053
+4,569
+70% +$238K ﹤0.01% 1437
2021
Q3 		$411K Sell
6,484
-6,506
-50% -$495K ﹤0.01% 1328
2021
Q2 		$1.19M Sell
12,990
-440
-3% -$35K ﹤0.01% 932
2021
Q1 		$914K Buy
13,430
+2,824
+27% +$219K ﹤0.01% 1044
2020
Q4 		$768K Buy
10,606
+4,737
+81% +$274K ﹤0.01% 1006
2020
Q3 		$223K Buy
5,869
+50
+0.9% +$1.69K ﹤0.01% 1359
2020
Q2 		$206K Buy
+5,819
New +$166K ﹤0.01% 1441

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

ProShare Advisors's CDNA Position: Q3 2025 in Review

ProShare Advisors sold out of CareDx (CDNA) in Q3 2025, closing a stake of 11,179 shares — an estimated $218K sold.

ProShare Advisors first reported a position in CDNA in Q2 2020 and held it in 12 quarters. The position peaked at $1.19M in Q2 2021. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • ProShare Advisors reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • ProShare Advisors sold 11,179 CareDx shares in Q3 2025, an estimated $218K.
  • ProShare Advisors first reported a position in CareDx in Q2 2020 and held it in 12 quarters.
  • ProShare Advisors's CareDx position peaked at $1.19M in Q2 2021.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on ProShare Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.